Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |